The OUD cohort, on the other hand, comprised of 6,613 cases and 6,613 controls (n = 13,226)
The safety profile of retatrutide was consistent with that of other incretin-based therapies
Molecular rejuvenation: In animal studies, GLP-1 drugs have reversed many age-related changes at the molecular level, including improving the function of genes and proteins involved in cell repair, energy production, and metabolism
Convenience Might Be the Game Changer The major selling point for orforglipron highlighted even by mainstream media, including a recent Time Magazine feature, is its simplicity and convenience
14 Researchers also found that glucose metabolism in the brain starts decreasing up to 18 years (mean, 14.1 years) before expected symptom onset, and brain atrophy begins up to 13 years (mean, 4.7 years) before expected symptom onset